Pieter Roelofs, PhD candidate at the Radiotherapy & OncoImmunology laboratory, Dept. of Radiation Oncology, was awarded a 3500 EUR travel grant from the René Vogels Stichting.He received the award in order to perform a work visit to prof. Reuben Harris’ lab at the University of Minnesota, Minneapolis, MN, USA. Pieter’s work is focused on the role of the DNA cytosine deaminase APOBEC3B in the development of therapy resistance in breast cancer. During his 14-months stay in Minneapolis as part of his KWF-funded project, he will investigate why this anti-viral enzyme is deregulated in a large proportion of breast tumors, leading to increased mutations and subsequent therapy resistance.
Pieter Roelofs is member of theme Women´s cancers.
Related news items
Nontuberculous mycobacteria and fungal co-infections Bonnie and Clyde?18 April 2019
In The European respiratory journal Jakko van Ingen and Sanne Zweijpfenning showed that 40% of patients diagnosed with nontuberculous mycobacterial pulmonary disease also meet diagnostic criteria for chronic pulmonary aspergillosis.read more
ESCMID award for groundbreaking studies on NTM disease18 April 2019
Jakko van Ingen received the ESCMID Young Investigator Award for his groundbreaking work on nontuberculous mycobacterial disease.read more
EU funded project BIOMAP led by Ellen van den Bogaard12 April 2019
Ellen van den Bogaard, theme Inflammatory diseases, leads the research on the experimental validation and functional analysis of identified biomarkers by using advanced organotypic skin models and receives a grant of €258,000.read more
Dosing anticancer drugs in patients with renal or hepatic impairment11 April 2019
Renal or hepatic impairment is a common comorbidity for patients with cancer either because of the disease itself, toxicity of previous anticancer treatments, or because of other factors affecting organ function, such as increased age.read more